2. Search Result
Search Result
Results for "

α-Amino-p-toluic acid

" in MedChemExpress (MCE) Product Catalog:

5

Inhibitors & Agonists

2

Peptides

1

Isotope-Labeled Compounds

Targets Recommended:
Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-B1258
    4-(Aminomethyl)benzoic acid
    1 Publications Verification

    Aminomethylbenzoic acid; α-Amino-p-toluic acid

    		 Amino Acid Derivatives Cancer
    4-(Aminomethyl)benzoic acid is a competitive inhibitor of PepT1 and has antifibrinolytic activity .
    4-(Aminomethyl)benzoic acid
  • HY-P10341
    ZP3022

    		GCGR Metabolic Disease
    ZP3022 is a dual agonist of glucagon-like peptide-1 (GLP-1) and gastrin that has the ability to sustainably improve glycemic control. Additionally, ZP3022 can effectively increase β-cell mass, promote β-cell proliferation, and enhance the function of pancreatic islets. ZP3022 can be used in anti-diabetic research .
    ZP3022
  • HY-B1258R
    4-(Aminomethyl)benzoic acid (Standard)

    Aminomethylbenzoic acid (Standard); α-Amino-p-toluic acid (Standard)

    		 Amino Acid Derivatives Reference Standards Others
    4-(Aminomethyl)benzoic acid (Standard) is the analytical standard of 4-(Aminomethyl)benzoic acid. This product is intended for research and analytical applications. 4-(Aminomethyl)benzoic acid is an unnatural amino acid derivative and an antifibrinolytic drug.
    4-(Aminomethyl)benzoic acid (Standard)
  • HY-B1258S
    Intermediate of tranexamic Acid-13C2,15N

    Aminomethylbenzoic acid-13C2,15N; α-Amino-p-toluic acid-13C2,15N

    		 Isotope-Labeled Compounds Amino Acid Derivatives Cancer
    Intermediate of tranexamic Acid- 13C2, 15N (Aminomethylbenzoic acid- 13C2, 15N) is 13C and 15N labeled 4-(Aminomethyl)benzoic acid. 4-(Aminomethyl)benzoic acid is a competitive inhibitor of PepT1 and has antifibrinolytic activity .
    Intermediate of tranexamic Acid-13C2,15N
  • HY-P10876
    mcK6A1

    		Amyloid-β Neurological Disease
    mcK6A1 is an inhibitor for the aggregation of amyloid-β (Aβ), that selectively binds to the 16KLVFFA21 segment of Aβ42, forms an extended β-folded structure, and inhibits the formation of Aβ42 oligomers. mcK6A1 can be used in research of Alzheimer's disease and other amyloid-related diseases .
    mcK6A1

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

  

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

  

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: